Skip to main content
. 2018 Aug 31;16(3):235–245. doi: 10.9758/cpn.2018.16.3.235

Fig. 2.

Fig. 2

Melatonin (any dosage) vs. placebo in adolescents or adults with bipolar disorder or schizophrenia receiving olanzapine or other atypical antipsychotic with high risk of metabolic disturbances. Outcome: mean change in body weight (kg) from baseline to endpoint.

SD, standard deviation; IV, inverse variance method; CI, confidence interval; df, degree of freedom.